Innovating Works

INFINIDAT

Desconocido
iReceptor Plus: ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T CELL RECEPTOR SEQUENCING DATA REPOSITORIES FO... INFINIDAT LTD participó en un H2020: H2020-SC1-BHC-2018-2020 Background: Many cutting-edge therapies rely on manipulating the adaptive immune system, which has evolved a vast diversity (repertoire) of...
2018-12-08 - 2022-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.